Max C Petersen

10PUBLICATIONS
14CO-AUTHORS
Molecular targetsMedical biochemistry - carbohydratesMedical biochemistry - lipidsEpigenetics (incl. genome methylation and epigenomics)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 28, 2026
Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis.

|Apr 22, 2025
Breath Acetone Correlates With Capillary β-hydroxybutyrate in Type 1 Diabetes.

Kai E Jones, Max C Petersen, Alexander M Markov

|Mar 14, 2025
Effect of dapagliflozin on blood and breath ketones during supervised insulin withdrawal in adults with type 1 diabetes: A randomized crossover trial.

Max C Petersen, Kai E Jones, Alexander M Markov

|Feb 20, 2025
Breath Acetone Correlates with Capillary β-hydroxybutyrate in Type 1 Diabetes.

Kai E Jones, Max C Petersen, Alexander M Markov

|Sep 12, 2024
Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People With Obesity and Type 2 Diabetes.

Max C Petersen, Mihoko Yoshino, Gordon I Smith

|Jan 16, 2024
Impaired plasma glucose clearance is a key determinant of fasting hyperglycemia in people with obesity.

Bettina Mittendorfer, Stephan van Vliet, Gordon I Smith

Pageof 2

Frequent Collaborators

3 joint publications

Samantha E Adamson

3 joint publications

Janet B McGill

3 joint publications

Samuel Klein

2 joint publications

Kathryn L Bohnert